Hint mode is switched on Switch off

Axonics Modulation Technologies, ordinary share
AXNX, US05465P1012

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Save Close
Axonics Modulation Technologies, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Axonics Modulation Technologies, Inc., a medical technology company, focuses on the design, development, and commercialization of sacral neuromodulation solutions (SNM) solutions. The SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and ...
Axonics Modulation Technologies, Inc., a medical technology company, focuses on the design, development, and commercialization of sacral neuromodulation solutions (SNM) solutions. The SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.
Show more Hide

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    AXNX
  • Placement
    31.10.2018
  • Lock up period
    180
  • Number of papers
    8,000,000
  • Volume of raised funds
    120 mln USD
  • Raised funds in USD
    -
  • Placement share
    30.03%
  • Final placement price
    15 USD
  • Price change since placement date
    -100%
  • By capitalization
    399.58 mln USD
Other placements of the issuer
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    AXNX
  • Placement
    11.05.2020
  • Lock up period
    180
  • Number of papers
    4,000,000
  • Volume of raised funds
    130 mln USD
  • Raised funds in USD
    -
  • Placement share
    10.39%
  • Final placement price
    32.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    1,251.6 mln USD

Indicators

IFRS/US GAAP reports

  • 2024

  • 2023

  • 2022

  • 2021

  • 2020

  • 2019

  • 2018

    • News

    All organization news

    Holders

    Industry Leaders

    Registration is required to get access.